News
The European agency has started a review of sodium oxybate to assess its use to treat alcohol withdrawal syndrome and support ...
The dapivirine ring was originally approved in July 2020 to reduce the risk for HIV-1 infection in women 18 years and older ...
The European Medicines Agency has begun a review of medicines to treat alcohol dependency that contain sodium oxybate, it said on Friday, following concerns of potential misuse or abuse. The regulator ...
The European Union's medicine regulator has begun a review of some medicines that contain sodium oxybate and are used to treat alcohol withdrawal syndrome, it said on Friday. Sodium oxybate is an ...
8h
GlobalData on MSNMadrigal poised to enter European MASH market after CHMP endorsementRevenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.
The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended five novel medicines for approval at its June 2025 meeting.
The European Medicines Agency has issued a positive opinion for the approval of a vaccine named Biobhyo, indicated to protect ...
ORION CORPORATION PRESS RELEASE 20 JUNE 2025 at 13.30 EEST CHMP recommends third indication for darolutamide for patients ...
The European Medicines Agency’s human medicines committee (CHMP) adopted positive opinions for six biosimilar medicines at its June meeting.
Madrigal Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of its Rezdiffra treatment for adults with the liver disease ...
In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...
European Commission decision expected in August 2025; if approved, resmetirom will be the first medication for people living with MASH in the E.U. CONSHOHOCKEN, Pa., June 20, 2025 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results